121 related articles for article (PubMed ID: 21640801)
1. Neuroblastoma cell proliferation is sensitive to changes in levels of RUNX1 and RUNX3 protein.
Inoue K; Ito Y
Gene; 2011 Nov; 487(2):151-5. PubMed ID: 21640801
[TBL] [Abstract][Full Text] [Related]
2. RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma.
Yu F; Gao W; Yokochi T; Suenaga Y; Ando K; Ohira M; Nakamura Y; Nakagawara A
Oncogene; 2014 May; 33(20):2601-9. PubMed ID: 23851507
[TBL] [Abstract][Full Text] [Related]
3. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
Fowler M; Borazanci E; McGhee L; Pylant SW; Williams BJ; Glass J; Davis JN; Meyers S
J Cell Biochem; 2006 Jan; 97(1):1-17. PubMed ID: 16237704
[TBL] [Abstract][Full Text] [Related]
4. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells.
Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H
Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375
[TBL] [Abstract][Full Text] [Related]
5. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.
Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y
Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation.
Brady G; Whiteman HJ; Spender LC; Farrell PJ
J Virol; 2009 Jul; 83(13):6909-16. PubMed ID: 19403666
[TBL] [Abstract][Full Text] [Related]
7. Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells.
Wallick CJ; Gamper I; Thorne M; Feith DJ; Takasaki KY; Wilson SM; Seki JA; Pegg AE; Byus CV; Bachmann AS
Oncogene; 2005 Aug; 24(36):5606-18. PubMed ID: 16007177
[TBL] [Abstract][Full Text] [Related]
8. Runx3/AML2/Cbfa3 regulates early and late chondrocyte differentiation.
Soung do Y; Dong Y; Wang Y; Zuscik MJ; Schwarz EM; O'Keefe RJ; Drissi H
J Bone Miner Res; 2007 Aug; 22(8):1260-70. PubMed ID: 17488194
[TBL] [Abstract][Full Text] [Related]
9. Expression profiles and clinical relationships of ID2, CDKN1B, and CDKN2A in primary neuroblastoma.
Gebauer S; Yu AL; Omura-Minamisawa M; Batova A; Diccianni MB
Genes Chromosomes Cancer; 2004 Dec; 41(4):297-308. PubMed ID: 15390183
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of Runx1 and Runx3 in mechanoreceptive dorsal root ganglion neurons.
Yoshikawa M; Murakami Y; Senzaki K; Masuda T; Ozaki S; Ito Y; Shiga T
Dev Neurobiol; 2013 Jun; 73(6):469-79. PubMed ID: 23378040
[TBL] [Abstract][Full Text] [Related]
11. Transcription Factors Runx1 and Runx3 Suppress Keratin Expression in Undifferentiated Keratinocytes.
Ogawa E; Edamitsu T; Ohmori H; Kohu K; Kurokawa M; Kiyonari H; Satake M; Okuyama R
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077435
[TBL] [Abstract][Full Text] [Related]
12. RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC.
Selvarajan V; Osato M; Nah GSS; Yan J; Chung TH; Voon DC; Ito Y; Ham MF; Salto-Tellez M; Shimizu N; Choo SN; Fan S; Chng WJ; Ng SB
Leukemia; 2017 Oct; 31(10):2219-2227. PubMed ID: 28119527
[TBL] [Abstract][Full Text] [Related]
13. SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastoma.
Evans L; Chen L; Milazzo G; Gherardi S; Perini G; Willmore E; Newell DR; Tweddle DA
Cancer Lett; 2015 Jul; 363(1):37-45. PubMed ID: 25843293
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells.
Spender LC; Whiteman HJ; Karstegl CE; Farrell PJ
Oncogene; 2005 Mar; 24(11):1873-81. PubMed ID: 15688019
[TBL] [Abstract][Full Text] [Related]
15. Runt-related transcription factor 1 promotes apoptosis and inhibits neuroblastoma progression in vitro and in vivo.
Hong M; He J; Li D; Chu Y; Pu J; Tong Q; Joshi HC; Tang S; Li S
J Exp Clin Cancer Res; 2020 Mar; 39(1):52. PubMed ID: 32197643
[TBL] [Abstract][Full Text] [Related]
16. How does MYCN amplification make neuroblastomas behave aggressively? Still more questions than answers.
Maris JM
Pediatr Blood Cancer; 2005 Dec; 45(7):869-70. PubMed ID: 16206200
[No Abstract] [Full Text] [Related]
17. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of RUNX3 Represses RUNX1 to Drive Transformation of Myelodysplastic Syndrome.
Yokomizo-Nakano T; Kubota S; Bai J; Hamashima A; Morii M; Sun Y; Katagiri S; Iimori M; Kanai A; Tanaka D; Oshima M; Harada Y; Ohyashiki K; Iwama A; Harada H; Osato M; Sashida G
Cancer Res; 2020 Jun; 80(12):2523-2536. PubMed ID: 32341038
[TBL] [Abstract][Full Text] [Related]
19. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression.
Liu PY; Erriquez D; Marshall GM; Tee AE; Polly P; Wong M; Liu B; Bell JL; Zhang XD; Milazzo G; Cheung BB; Fox A; Swarbrick A; Hüttelmaier S; Kavallaris M; Perini G; Mattick JS; Dinger ME; Liu T
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24906397
[TBL] [Abstract][Full Text] [Related]
20. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM
Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
